GlucoTrack Inc
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the… Read more
GlucoTrack Inc (GCTK) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -1.680x
Based on the latest financial reports, GlucoTrack Inc (GCTK) has a cash flow conversion efficiency ratio of -1.680x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.62 Million) by net assets ($2.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
GlucoTrack Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how GlucoTrack Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
GlucoTrack Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GlucoTrack Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anacomp Inc
PINK:ANMP
|
0.282x |
|
Gulf & Pacific Equities Corp
V:GUF
|
0.042x |
|
PULTEGROUP - Dusseldorf Stock Exchang
DU:PU7
|
0.039x |
|
AMEREN - Dusseldorf Stock Exchang
DU:AE4
|
0.002x |
|
Total Helium Ltd
OTCQB:TTLHF
|
0.000x |
|
Axim Biotechnologies Inc
PINK:AXIM
|
0.065x |
|
AGILENT TECH (AG8.SG)
STU:AG8
|
0.077x |
|
Mlabs Systems Bhd
KLSE:0085
|
-0.346x |
Annual Cash Flow Conversion Efficiency for GlucoTrack Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of GlucoTrack Inc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-13.00 Million | $-12.49 Million | 0.961x | +146.84% |
| 2023-12-31 | $3.20 Million | $-6.56 Million | -2.051x | +32.34% |
| 2022-12-31 | $1.23 Million | $-3.73 Million | -3.032x | -314.66% |
| 2021-12-31 | $5.16 Million | $-3.77 Million | -0.731x | -87.58% |
| 2020-12-31 | $8.98 Million | $-3.50 Million | -0.390x | -114.12% |
| 2019-12-31 | $-1.41 Million | $-3.90 Million | 2.761x | +62.18% |
| 2018-12-31 | $-2.87 Million | $-4.89 Million | 1.703x | +378.73% |
| 2017-12-31 | $-16.57 Million | $-5.90 Million | 0.356x | -26.69% |
| 2016-12-31 | $-10.95 Million | $-5.31 Million | 0.485x | -25.92% |
| 2015-12-31 | $-6.97 Million | $-4.57 Million | 0.655x | -5.86% |
| 2014-12-31 | $-4.83 Million | $-3.36 Million | 0.696x | +139.18% |
| 2013-12-31 | $-11.06 Million | $-3.22 Million | 0.291x | -93.63% |
| 2012-12-31 | $-503.07K | $-2.30 Million | 4.566x | +330.72% |
| 2011-12-31 | $968.24K | $-1.92 Million | -1.979x | -- |